Post-stent chest pain, revisited
Heart Sisters
JULY 28, 2024
Heart patients with persistent or recurrent post-stent chest pain present “an unmet clinical need”, according to the European Journal of Cardiology.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Heart Sisters
JULY 28, 2024
Heart patients with persistent or recurrent post-stent chest pain present “an unmet clinical need”, according to the European Journal of Cardiology.
Frontiers in Cardiovascular Medicine
MARCH 16, 2025
BackgroundAn undeflatable stent balloon following its inflation during percutaneous coronary intervention (PCI) is a rare and unpredictable complication that can lead to serious consequences. Following stent deployment, the balloon failed to deflate and remained inflated within the LAD.
Med Page Today
APRIL 8, 2024
(MedPage Today) -- ATLANTA -- The concept of using stents to seal off non-flow-limiting vulnerable plaques, before they have a chance to rupture, worked out in the first major trial testing this provocative idea. Compared with standard medical.
DAIC
JUNE 12, 2024
and an investigator in the VIVID study , which contributed to the device’s FDA approval – successfully used the Duo Venous Stent System for the first time outside of a clinical trial. Duo Hybrid has a distinct integrated design that combines multiple zones of differing mechanical properties into a single stent [3].
Medical Xpress - Cardiology
DECEMBER 27, 2024
A Korea Institute of Science and Technology (KIST) research team has developed a novel stent surface treatment technology using laser patterning. This technology promotes endothelial cell growth while inhibiting smooth muscle cell dedifferentiation in blood vessels.
Medical Xpress - Cardiology
FEBRUARY 21, 2024
Using intravascular imaging to guide stent implantation during percutaneous coronary intervention (PCI) in heart disease patients significantly improves survival and reduces adverse cardiovascular events compared to angiography-guided PCI alone, the most commonly used method.
JAMA Cardiology
OCTOBER 8, 2024
This systematic review and network meta-analysis investigates the optimal duration of dual antiplatelet therapy in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention with drug-eluting stents.
DAIC
APRIL 17, 2024
milla1cf Wed, 04/17/2024 - 16:18 April 17, 2024 — Getinge and Cook Medical announced an exclusive sales and distribution agreement for the iCast covered stent system, which has been on the market for twenty years and recently received premarket approval for treatment of iliac arterial occlusive disease.
Medical Xpress - Cardiology
APRIL 1, 2025
Using intravascular imaging (IVI) to guide stent implantation during complex stenting procedures is safer and more effective for patients with severely calcified coronary artery disease than conventional angiography, the more commonly used technique.
American College of Cardiology
MARCH 29, 2025
After stent implantation, a three-month regimen of dual antiplatelet therapy (DAPT) was more effective than a one-month regimen at reducing adverse events without increasing bleeding risk in patients with a high bleeding risk (HBR), according to a Late-Breaking Clinical Trial presented at ACC.25 25 in Chicago.
Frontiers in Cardiovascular Medicine
DECEMBER 18, 2023
Objectives There is no consensus regarding the optimal choice between single long stent (SLS) and overlapped double short stents (DSS) in patients with acute myocardial infarction (AMI). Therefore, we aimed to compare treatment outcomes among patients with AMI treated with these two different stenting methods. years, and 75.0%
Becker's Hospital Review - Cardiology
JUNE 3, 2024
based HonorHealth Research and Innovation Institute is among the first facilities in the nation — and one of 30 worldwide — to use new stroke prevention stents, according to a May 29 news release. Scottsdale, Ariz.-based
JAMA Cardiology
MARCH 12, 2024
This randomized clinical trial compares 12-month event rates using quantitative coronary angiography guidance during percutaneous coronary intervention with those after intravascular ultrasonography–guided stent implantation.
Med Page Today
APRIL 29, 2024
(MedPage Today) -- The FDA approved the Esprit BTK everolimus-eluting scaffold system for chronic limb-threatening ischemia (CLTI) below the knee, Abbott announced on Monday. This system represents the first drug-eluting resorbable scaffold with.
Becker's Hospital Review - Cardiology
JUNE 20, 2024
based Atrium Health Sanger Heart & Vascular Institute has become the first in the world to implant a new Duo venous stent system. Charlotte, N.C.-based
HCPLive
APRIL 29, 2024
Abbott's Esprit BTK System was shown to significantly reduce risk of ischemic events in patients with PAD versus angioplasty over 1 year.
The American Journal of Cardiology
APRIL 9, 2025
Publication date: Available online 8 April 2025 Source: The American Journal of Cardiology Author(s): Subhash Banerjee, David Fernandez Vazquez, Yu-Lun Liu, Sameh Sayfo, Minseob Jeong, Zachary P. Rosol, Anand Gupta, Blake M. Bruneman, Sarah G. Weideman, Kennedy S. Adelman, Shirling Tsai, Shuaib Abdullah, Hung B. Chu, Bertram L. Smith, Bradley R.
Science Daily - Heart Disease
APRIL 8, 2024
New research could change standard-of-care guidelines to improve outcomes for heart attack patients after coronary stenting procedures.
Med Page Today
SEPTEMBER 1, 2024
(MedPage Today) -- LONDON -- Some individuals already undergoing transcatheter aortic valve replacement (TAVR, also TAVI) might as well get coronary lesions revascularized around the same time, according to the NOTION-3 randomized trial. Clinical.
Frontiers in Cardiovascular Medicine
JANUARY 31, 2024
Objectives The purpose of this study was to assess the clinical outcome after right ventricular outflow tract (RVOT) stenting in late presenter patient with unrepaired Fallot physiology. Results During the procedure, the average stent diameter and length were 8.84 ± 1.64 mm The Statistical Package for Social Science (SPSS) 26.0
Coronary Artery Disease Journal
JULY 30, 2024
No abstract available
DAIC
OCTOBER 16, 2024
Smits and a distinguished team of international researchers, the trial compares the performance of SMT's biodegradable-polymer sirolimus-eluting Supraflex Cruz stent with the biodegradable-polymer Ultimaster Tansei * stent in patients with high bleeding risk (HBR) undergoing abbreviated dual antiplatelet therapy (DAPT).
Becker's Hospital Review - Cardiology
JANUARY 23, 2025
Florida and Illinois have the most top-ranked hospitals for stent placement in the U. according to the WebMD Choice Awards.
DAIC
MARCH 8, 2024
a company focused on reducing the risk of stroke and its devastating impact, today announced that it has launched its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States. New tapered configurations for our ENROUTE Transcarotid Stent System build upon the robust portfolio of Silk Road’s carotid solutions.
Frontiers in Cardiovascular Medicine
JULY 25, 2024
The past five years have yielded impressive advancements in fully absorbable metal stent technology. Nowhere is the need for fully absorbable metal stents greater than in patients experiencing vascular anomalies associated with congenital heart disease (CHD).
Frontiers in Cardiovascular Medicine
DECEMBER 13, 2023
A hybrid technique using a single-branched thoracic stent-graft (Castor, MicroPort Medical, Shanghai, China) in combination with a surgical left subclavian-carotid bypass and endovascular occlusion of the poststenotic aneurysm using a vascular plug device (Amplatzer Vascular Plug, Abbott, Chicago, United States) was performed.
The American Journal of Cardiology
MARCH 29, 2025
Publication date: Available online 29 March 2025 Source: The American Journal of Cardiology Author(s): Thomas R. Basala, Muhmmad S.
Med Page Today
OCTOBER 28, 2024
(MedPage Today) -- For percutaneous coronary intervention (PCI) on de novo lesions, the DynamX bioadaptor not only matched drug-eluting stents (DES) in early performance but seemed to keep stent-related events from accruing after 6 months, according.
American College of Cardiology
OCTOBER 30, 2024
Results from the FLASH trial demonstrate the noninferiority of artificial intelligence-based fully automated quantitative coronary angiography (AI-QCA)-assisted PCI compared with optical coherence tomography (OCT)-guided PCI in achieving optimal minimal stent area, with comparable procedural complications, OCT-defined endpoints, and six-month clinical (..)
Frontiers in Cardiovascular Medicine
JANUARY 7, 2024
Introduction The use of contemporary drug-eluting stents (DES) has significantly improved outcomes of patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI). cases, the target lesion was in-stent restenosis (ISR). Results A total of 425 patients were enrolled at 13 centers (mean age 66.9 ± 11.6
Cardiology Update
JULY 28, 2024
A recent study published in JACC: Cardiovascular Interventions has provided new insights into the long-term management of patients suffering from recurrent in-stent restenosis (ISR), a condition presenting notable challenges in cardiovascular treatment. The median follow-up period was 10.3 Original article: Koch T et al.
Becker's Hospital Review - Cardiology
NOVEMBER 7, 2024
A drug-eluting resorbable stent was found to be just as effective in treating infrapopliteal artery disease in patients at risk of limb amputation, according to a study published Oct. 25 in the New England Journal of Medicine.
Journal of Cardiovascular Electrophysiology
NOVEMBER 20, 2024
The stenosis was treated with a stent. years later he presented with an in-stent restenosis that was successfully treated with a stent-in-stent strategy. Conclusion Our case demonstrates stenting as a viable alternative strategy with potentiallyfavorable long-term outcome.
Med Page Today
JULY 25, 2024
(MedPage Today) -- For interventionalists hoping that a new generation of coronary balloons might improve treatment of in-stent restenosis (ISR), contemporary registry data were encouraging. In a propensity score-matched analysis of 335 pairs.
American College of Cardiology
SEPTEMBER 2, 2024
The goal of the REC-CAGEFREE I trial was to assess the safety and efficacy of a paclitaxel-coated balloon (DCB) compared to drug-eluting stent (DES) implantation among patients with coronary in-stent restenosis.
DAIC
JANUARY 31, 2024
(Gore) announced recent FDA approval of a lower profile GORE VIABAHN VBX Balloon Expandable Endoprosthesis ( VBX Stent Graft ). 1-3 "Our team is pleased to be the first commercial implanter of the new lower profile VBX Stent Graft," said Darren Schneider , M.D., No changes to the stent design were made to achieve the lower profile.
Frontiers in Cardiovascular Medicine
DECEMBER 21, 2023
Background In acute coronary syndrome (ACS), a number of previous studies tried to identify the risk factors that are most likely to influence the rate of in-stent restenosis (ISR), but the contribution of these factors to ISR is not clearly defined.
JAMA Cardiology
NOVEMBER 26, 2024
This study compares clopidogrel vs aspirin monotherapy in patients with high bleeding risk and/or percutaneous coronary intervention complexity.
Frontiers in Cardiovascular Medicine
FEBRUARY 18, 2024
Drug-eluting stents (DES) play a crucial role in treating coronary artery disease (CAD) by preventing restenosis. These stents are coated with drug carriers that release antiproliferative drugs within the vessel. The most cited document pertained to standardized definitions for clinical endpoints in coronary stent trials.
Medical Xpress - Cardiology
NOVEMBER 7, 2024
A study at Mayo Clinic suggests that an hourglass-shaped stent could improve blood flow and ease severe and reoccurring chest pain in people with microvascular disease. Of 30 participants in a phase 2 clinical trial, 76% saw improvement in their day-to-day life.
Med Page Today
MARCH 16, 2024
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center.
DAIC
JANUARY 19, 2024
announced that the first patients have been enrolled in the Gore VBX FORWARD Clinical Study ( NCT05811364 ), a global prospective, multicenter, randomized controlled trial to compare the GORE VIABAHN VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) to bare metal stenting for patients with complex iliac occlusive disease. "Our
The American Journal of Cardiology
JANUARY 24, 2025
Publication date: Available online 23 January 2025 Source: The American Journal of Cardiology Author(s): Daisuke Nakamura, Isamu Mizote, Takayuki Ishihara, Yutaka Matsuhiro, Shota Okuno, Tatsuya Shiraki, Takuya Tsujimura, Naotaka Okamoto, Naoki Itaya, Takaharu Nakayoshi, Atsushi Kikuchi, Tsutomu Kawai, Yuhei Nojima, Mitsuyoshi Takahara, Takashi Morita, (..)
Frontiers in Cardiovascular Medicine
JANUARY 7, 2024
In the present case, a 76-year-old hypertensive woman was admitted with dizziness and diagnosed with an unruptured bronchial artery aneurysm, which was treated by transcatheter arterial embolization and aortic stent-graft. The patient's clinical status was stable during the 4-year follow-up.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content